Cart
sales@molnova.com
Epoxiconazole
CAS No. 133855-98-8
Epoxiconazole( BAS 480F | BAS480F | BAS-480F | EC 406 850 2 | EC-406-850-2 )
Catalog No. M27138 CAS No. 133855-98-8
Epoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 37 | Get Quote |
|
| 25MG | 67 | Get Quote |
|
| 50MG | 87 | Get Quote |
|
| 100MG | 141 | Get Quote |
|
| 200MG | 213 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEpoxiconazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionEpoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.
-
DescriptionEpoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.
-
In Vitro——
-
In Vivo——
-
SynonymsBAS 480F | BAS480F | BAS-480F | EC 406 850 2 | EC-406-850-2
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
Recptorδ-opioid receptor| μ-opioid receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number133855-98-8
-
Formula Weight329.76
-
Molecular FormulaC17H13ClFN3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (303.25 mM)
-
SMILESFc1ccc(cc1)C1(Cn2cncn2)OC1c1ccccc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mónica García, et al. Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ 1 Receptor Antagonist Clinical Candidate for the Treatment of Pain. J Med Chem. 2020 Oct 16.
molnova catalog
related products
-
Garenoxacin
A quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.
-
PBP 10
Selective formyl peptide receptor 2 (FPR2) antagonist; cell permeable. Selectively inhibits FPR2-mediated NADPH oxidase activity but has no effect on FPR1 signaling in neutrophils. Displays PIP2 binding activity in vitro and blocks cell motility. Also exhibits antiviral activity against influenza viruses via inhibition of viral-induced ERK activation.
-
Doripenem
Doripenem is a new parenteral carbapenem antibiotic with broad-spectrum activity against gram-negative and gram-positive pathogens.
